Previous 10 | Next 10 |
home / stock / bhsc:cc / bhsc:cc news
Study will assess the Capacity of its Red Grape Cell (RGC) Botanical Composition to Promote Eye Health Study is first to demonstrate potential capabilities of BioHarvest's Botanical-Synthesis t echnology to provide consistent APIs, adjuvants and drugs for pharmaceutical industry Vancouv...
Finished 2022 with Q4 sales orders of USD 2.7M representing a 3.3X increase over Q4 2021 Sales orders growth for 2023 is projected to be 3X of 2022 and reach USD 17.3M – USD 20.3M Cash flow break even projected for Q4 2023 Reassessment of commercialization timing of Cannabis and...
Dr. Garibaldi's 40 years of experience brings industry-leading pharmaceuticals development expertise to the Scientific Board of Advisors. His appointment demonstrates the company's resolve to leverage its biotechnology platform for enabling drugs development. Vancouver, British Columbia and Re...
Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - January 11, 2023) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB:CNVCF) ("BioHarvest" or "the Company") invites its shareholders and the general public to join a Live Video Conference ("Webinar") on Thursday, January 19, 20...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 29, 2022) - BioHarvest Sciences Inc. ("BioHarvest" or the "Company") (CSE: BHSC) (OTCQB: CNVCF) is pleased to provide the following year-end shareholder partner letter from CEO Ilan Sobel. Dear Shareholder Partner, Wha...
Cash flow break-even projected for Q4 2023 Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - December 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or "the Company") is estimating 2023 revenue to be between USD $17M-20M, repres...
This collaboration ensures first-of-their-kind consistent cannabinoid compositions for 575 DEA-licensed cannabis medical research institutions developing cures for PTSD, pain management, anxiety conditions and more Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 16...
This press release does not constitute an offer to sell or a solicitation to buy any securities in any jurisdiction. Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 15, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or t...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 14, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that CEO Ilan Sobel will host an online investor presentation on Wednesday, November 16. Following ...
NEW YORK, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the October Cannabis Virtual Investor Conference are now available for on-demand viewing. REGISTER NOW OR LOGIN AT:...
News, Short Squeeze, Breakout and More Instantly...
Bioharvest Sciences Inc. Company Name:
BHSC:CC Stock Symbol:
CNQC Market:
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of BioHarvest Sciences Inc. (OTCQB: CNVCF, CSE: BHSC). The in-depth 35-page initiation report includes detailed informat...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) (FSE: 8MV) ("BioHarvest" or the "Company") has closed the first tranche of its private placement announced on June 21, 2024. The Company issued 603,904 sh...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 24, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCD) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical Synthesis technology platform, today announced that management will present a...